Free Trial
NASDAQ:BTCY

Biotricity (BTCY) Stock Price, News & Analysis

Biotricity logo
$0.06 +0.00 (+5.45%)
As of 11/13/2026 12:45 PM Eastern

About Biotricity Stock (NASDAQ:BTCY)

Advanced

Key Stats

Today's Range
$0.06
▼
$0.06
50-Day Range
$0.04
▼
$0.11
52-Week Range
$0.04
▼
$0.58
Volume
47,315 shs
Average Volume
53,939 shs
Market Capitalization
$1.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biotricity, Inc. (NASDAQ: BTCY) is a medical technology company focused on remote cardiac monitoring and diagnostic solutions. The company develops connected medical devices and digital health technologies designed to help physicians and healthcare providers monitor patients outside traditional clinical settings.

Its product portfolio includes Bioflux, a mobile cardiac telemetry system designed to provide real-time electrocardiogram monitoring and arrhythmia detection, and Biotres, a wearable cardiac monitor intended to support multiple types of ambulatory monitoring. Biotricity also offers Bioheart, a personal cardiac monitoring device designed to help users track heart rate and related cardiac data.

Biotricity’s solutions combine wearable hardware, wireless connectivity, data-management software and monitoring services. The company primarily serves healthcare providers, medical practices and patients, with its operations centered in the United States. Biotricity was founded by Waqaas Ahmed, who serves as its chief executive officer.

AI Generated. May Contain Errors.

Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BTCY Stock News Headlines

Biotricity Q3 2026 Earnings Call: Complete Transcript
I'm handing you this stock today
Elon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.tc pixel
Biotricity, Inc. (BTCY) Q3 2026 Earnings Call Transcript
Biotricity Inc.
See More Headlines

BTCY Stock Analysis - Frequently Asked Questions

Biotricity's stock was trading at $0.30 at the beginning of 2026. Since then, BTCY shares have decreased by 80.0% and is now trading at $0.06.

Biotricity, Inc. (NASDAQ:BTCY) announced its quarterly earnings data on Wednesday, February, 11th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.08) by $0.04. The firm had revenue of $3.99 million for the quarter.
Read the conference call transcript
.

Shares of Biotricity reverse split on the morning of Monday, July 3rd 2023.The 1-6 reverse split was announced on Monday, July 3rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, July 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Biotricity (BTCY) raised $15 million in an initial public offering on Thursday, August 26th 2021. The company issued 5,000,000 shares at a price of $3.00 per share. H.C. Wainwright & Co. acted as the underwriter for the IPO.

Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biotricity investors own include Tesla (TSLA), Ford Motor (F), NVIDIA (NVDA), SoFi Technologies (SOFI), Opendoor Technologies (OPEN), Plug Power (PLUG) and Canopy Growth (CGC).

Company Calendar

Today
11/14/2026
Fiscal Year End
3/31/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:BTCY
Previous Symbol
OTCMKTS:BTCY
CIK
1630113
Fax
N/A
Employees
46
Year Founded
2014

Profitability

EPS (Trailing Twelve Months)
($0.14)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.09 million
Net Margins
-80.42%
Pretax Margin
-80.42%
Return on Equity
N/A
Return on Assets
-188.47%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.23
Quick Ratio
0.10

Sales & Book Value

Annual Sales
$12.06 million
Price / Sales
0.10
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.30) per share
Price / Book
-0.05

Miscellaneous

Outstanding Shares
20,075,000
Free Float
22,075,000
Market Cap
$1.20 million
Optionable
No Data
Beta
1.03

Social Links

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NASDAQ:BTCY) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners